Rick Matthews/LikedIn
Mar 9, 2026, 13:49
Rick Matthews: Looking Beyond Clot Clearance in Long-Term Management After DVT
Rick Matthews, Senior Vascular Consultant at Argon Medical Devices, Inc., shared on LinkedIn:
”We talk a lot about ‘clearing clot today’ with modern mechanical thrombectomy/PMT options, but the long game is what patients live with: recurrent ipsilateral DVT risk, valve injury, chronic outflow obstruction, and structured follow-up.
Are you routinely documenting Villalta at 3–6 months after DVT (and repeating at ~12 months), or is it still inconsistent across services?
PTS symptoms often reflect the net effect of obstruction plus reflux plus microvascular injury—so the pathway has to be stepwise.
My simple escalation triggers (baked into any VTE program):
- Villalta ≥10 / meaningful functional limitation
- Venous claudication
- Skin changes or ulcer
- New/worsening swelling – rule out recurrent DVT first”
Stay updated with Hemostasis Today.
-
Sep 18, 2026, 14:52Abdul Muqtadir Abbasi: How Do Hematologists Know Which Coagulation Factor Is the Problem?
-
Sep 18, 2026, 14:48Kato Ramaekers: Redefining Integrin αIIbβ3 in Platelet Formation
-
Sep 18, 2026, 14:33Heghine Khachatryan: The discussion of Thrombophilia, APS and Coagulation Testing
-
Sep 18, 2026, 14:27Maria Cherska: Are We Overlooking the Spleen in Cardiometabolic Research?
-
Sep 18, 2026, 14:05Wolfram Ruf: Managing Thrombotic Risk in Pregnancy
-
Sep 18, 2026, 13:38Sam Tsimikas: Uncovering a Modifiable Lp(a) Phenotype in Hypertriglyceridemia
-
Sep 18, 2026, 13:22Christine Rabinak: Predictive Modeling for Individualized Unfractionated Heparin Dosing
-
Sep 18, 2026, 13:07Bastu Odoka: Principles of Pediatric Transfusion Dosing
-
Sep 18, 2026, 12:54David McIntosh: Plasma Therapies and the Unfinished Global Access Mission